Enzyme Advising Group is proud to be honored as a 2021 IBM Beacon Award winner for the Smart Diagnosis Platform in the Outstanding Cloud & AI Embed Solution category. Now in its 22nd year, the IBM Beacon Awards celebrate the next generation of innovators, creators and thinkers that use IBM technology, like hybrid cloud and artificial intelligence, to power innovative solutions for partners and their clients.
Supported and hosted on IBM Cloud , the Smart Diagnosis Platform is an AI-based image diagnostic solution that facilitates the process of creating new visual diagnostics tools (image collection, annotation and training), which identifies early warning signs and offering preliminary diagnosis automatically.
Enzyme Advising Group was selected as a Beacon Award winner by a panel of judges including industry specialists, IBM executives and analysts who recognized how its Smart Diagnosis Platform enables client success with IBM technology. The successful application of Artificial Intelligence in image analysis has positioned Enzyme as one of the main players in the implementation of this technology, making it one of the main components of Enzyme’s service offering.
As an IBM Beacon Award winner, Enzyme Advising Group will be a featured exhibitor at THINK 2021.
For more information on the 2021 IBM Beacon Awards, including a detailed list of winners, please visit here.
To learn more about Enzyme Advising Group, www.enzymeadvisinggroup.com
